Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
• Immunomedics, Inc. (NASDAQ:IMMU) stock rose 31.29% to $28.87 during Thursday's pre-market session. The most recent rating by H.C. Wainwright, on Apr 23, is at Buy, with a price target of $60.
• Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock rose 11.78% to $13.09. The most recent rating by Cantor Fitzgerald, on Apr 15, is at Overweight, with a price target of $13.
• Dynavax Technologies, Inc. (NASDAQ:DVAX) stock rose 11.11% to $3.60. The most recent rating by H.C. Wainwright, on Mar 12, is at Buy, with a price target of $12.
• Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares rose 10.19% to $16.44.
• Neptune Wellness Solns, Inc. (NASDAQ:NEPT) shares increased by 10.05% to $2.08. According to the most recent rating by Cowen & Co., on Jan 31, the current rating is at Market Perform.
• Neon Therapeutics, Inc. (NASDAQ:NTGN) stock moved upwards by 10.03% to $3.40.
• Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) shares rose 9.47% to $7.40. The most recent rating by RBC Capital, on Apr 23, is at Outperform, with a price target of $20.
• Alkermes, Inc. (NASDAQ:ALKS) shares increased by 9.45% to $17.61. The most recent rating by Morgan Stanley, on Apr 2, is at Equal-Weight, with a price target of $16.
• BioNTech, Inc. (NASDAQ:BNTX) stock rose 9.31% to $58.48. The most recent rating by H.C. Wainwright, on Apr 13, is at Neutral, with a price target of $48.
• Moleculin Biotech, Inc. (NASDAQ:MBRX) stock rose 9.26% to $1.18.
Losers
• Immunic, Inc. (NASDAQ:IMUX) shares declined 12.52% to $9.50 during Thursday's pre-market session.
• Sonnet BioTherapeutics, Inc. (NASDAQ:SONN) stock fell 11.04% to $5.40.
• Streamline Health Solns, Inc. (NASDAQ:STRM) shares declined 10.77% to $0.85.
• electroCore, Inc. (NASDAQ:ECOR) shares fell 9.32% to $1.07. The most recent rating by H.C. Wainwright, on Mar 24, is at Buy, with a price target of $2.
• SCYNEXIS, Inc. (NASDAQ:SCYX) stock decreased by 6.75% to $0.78.
• Avita Medical, Inc. (NASDAQ:RCEL) shares declined 4.41% to $5.85. The most recent rating by BTIG Research, on Mar 3, is at Buy, with a price target of $10.
• Heat Biologics, Inc. (NASDAQ:HTBX) stock declined 3.97% to $0.55. The most recent rating by Maxim Group, on Feb 6, is at Buy, with a price target of $1.
• Akorn, Inc. (NASDAQ:AKRX) shares decreased by 3.48% to $0.28.
• Vaxart, Inc. (NASDAQ:VXRT) stock fell 3.39% to $2.85.
• Cocrystal Pharma, Inc. (NASDAQ:COCP) stock fell 3.30% to $0.88.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!